F, S., C, L., & C, S. (2022). Decision-making on listing new medicines for public funding in New Zealand: The case of 'new' type 2 diabetes medications. Journal of primary health care, 14(1), 13. https://doi.org/10.1071/HC21122
Chicago Style (17th ed.) CitationF, Sarkisova, Lessing C, and Stretton C. "Decision-making on Listing New Medicines for Public Funding in New Zealand: The Case of 'New' Type 2 Diabetes Medications." Journal of Primary Health Care 14, no. 1 (2022): 13. https://doi.org/10.1071/HC21122.
MLA (9th ed.) CitationF, Sarkisova, et al. "Decision-making on Listing New Medicines for Public Funding in New Zealand: The Case of 'New' Type 2 Diabetes Medications." Journal of Primary Health Care, vol. 14, no. 1, 2022, p. 13, https://doi.org/10.1071/HC21122.